Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

 We would like to inform you that appeal filed by Saravana Global Holdings Limited against the Order dated 04th July, 2019 passed by the Adjudicating Authority (National Company Law Appellate Tribunal), New Delhi in Company Appeal (AT) (Insolvency) No.203 of 2019 with Supreme Court of India vide Case No. C.A.No.005344/2019 has been dismissed. Please find attached Supreme Court Order dismissing appeal filed by Saravana Global Holdings Limited. This is for your information and record.
16-07-2019
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Bafna Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
12-07-2019
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

 Sub.:- Update on National Company Law Appellate Tribunal (NCLAT), New Delhi Order We would like to inform you that appeal filed by Saravana Global Holdings Limited against the Order dated 1st February, 2019 passed by the Adjudicating Authority (National Company Law Tribunal), Single Bench, Chennai in MA/71/2019 in CP/682/IB/CB/2017 with National Company Law Appellate Tribunal (NCLAT), New Delhi has been dismissed. Please find attached National Company Law Appellate Tribunal (NCLAT), New Delhi Order dismissing appeal filed by Saravana Global Holdings Limited.
05-07-2019
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Sub.:- Discrepancies in Voting Result Ref.:- Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 / 24th annual general meeting held on 27th June 2019 We acknowledge the receipt of your email dated 04th July 2019 and rectified the discrepancy in the voting result. Please find attached rectified voting result. We request you to take the above information on your record
05-07-2019
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Sub.:- Voting Result and Scrutinizer Report of AGM held on 27th June 2019 Ref.:- Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find attached voting result of the 24th Annual General Meeting held on 27th June 2019 along with scrutinizer report. We request you to take the above information on your record.
29-06-2019
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Sub.:- Proceedings of 24th annual general meeting held on 27th June 2019 Ref.:- Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please be informed that the 24th AGM of the Company was held on 27th June 2019 at 3.00 P.M. at Andhra Social and Cultural Association, Krishna Hall, No.22, Vijayaraghava Road, T. Nagar, Chennai - 600 017 to transact the businesses as stated in the notice dated 27th May 2019, convening the AGM. In this regard please find attached the summary of the proceedings of the AGM of the Company. The voting results of the 24th Annual General Meeting of the Company along with the Scrutinizer report will be shared shortly. The 24th Annual General Meeting of the Company was concluded at 03.45 P.M.
27-06-2019
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Related Party Transactions

 Sub.:- Disclosure under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Details of Related party transactions In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, We hereby submit related party transactions as at 31st March 2019.
24-06-2019
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report03/06/2019 3 Name of the Certifying Firm A.K.JAIN & ASSOCIATES 4 Name of the Certifying Individual BALU SRIDHAR 5Membership TypeACS 6 Membership Number 5869 7 CP No. 3550 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes
13-06-2019
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Corporate Action- Book Closure For The Purpose Of Annual General Meeting

 Sub.:- Book closure for the purpose of Annual General Meeting Ref.:- Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We would like to inform you that, further to our announcement dated 27th May 2019 the Company's register of members will be closed from 24th June 2019 to 27th June 2019 (both days inclusive) for the purpose of annual general meeting. Security Code Type of security and paid up value Book closure Record date Purpose From to 532989 (BSE) BAFNAPHARM(NSE) Equity shares Rs.10/- paid up 24th June 2019 (Monday) 27th June 2019 (Thursday) Both day inclusive N.A Annual General Meeting scheduled to be held on 27th June 2019 This is for your information and record.
08-06-2019
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Fixes Book Closure for AGM

 Bafna Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 24, 2019 to June 27, 2019 (both days inclusive) for the purpose of 24th Annual General Meeting (AGM) of the Company to be held on June 27, 2019.
07-06-2019
Next Page
Close

Let's Open Free Demat Account